RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cronos Group Stock

Cronos Group P/E 2025

Cronos Group P/E

-42.04

Ticker

CRON.TO

ISIN

CA22717L1013

WKN

A2DMQY

As of Jan 15, 2025, Cronos Group's P/E ratio was -42.04, a 80.2% change from the -23.33 P/E ratio recorded in the previous year.

The Cronos Group P/E history

Cronos Group Aktienanalyse

What does Cronos Group do?

Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Cronos Group's P/E Ratio

The Price to Earnings (P/E) Ratio of Cronos Group is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Cronos Group's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Cronos Group is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Cronos Group’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Cronos Group stock

What is the price-to-earnings ratio of Cronos Group?

The price-earnings ratio of Cronos Group is currently -42.04.

How has the price-earnings ratio of Cronos Group changed compared to last year?

The price-to-earnings ratio of Cronos Group has increased by 80.2% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Cronos Group high compared to other companies?

Yes, the price-to-earnings ratio of Cronos Group is high compared to other companies.

How does an increase in the price-earnings ratio of Cronos Group affect the company?

An increase in the price-earnings ratio of Cronos Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Cronos Group affect the company?

A decrease in the price-earnings ratio of Cronos Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Cronos Group?

Some factors that influence the price-earnings ratio of Cronos Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Cronos Group pay?

Over the past 12 months, Cronos Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cronos Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Cronos Group?

The current dividend yield of Cronos Group is .

When does Cronos Group pay dividends?

Cronos Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cronos Group?

Cronos Group paid dividends every year for the past 0 years.

What is the dividend of Cronos Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cronos Group located?

Cronos Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cronos Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cronos Group from 1/15/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/15/2025.

When did Cronos Group pay the last dividend?

The last dividend was paid out on 1/15/2025.

What was the dividend of Cronos Group in the year 2024?

In the year 2024, Cronos Group distributed 0 USD as dividends.

In which currency does Cronos Group pay out the dividend?

The dividends of Cronos Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cronos Group stock can be added to a savings plan with the following providers: Trade Republic and Scalable Capital

Andere Kennzahlen von Cronos Group

Our stock analysis for Cronos Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cronos Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.